PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition–Dependent GSK-3β–Mediated c-Myc and Pim-1 Proteasomal DegradationMario Scarpa, Maria R. Baer|Molecular Cancer Therapeutics|2021Cited by 25
Pim kinase inhibitor co-treatment decreases alternative non-homologous end-joining DNA repair and genomic instability induced by topoisomerase 2 inhibitors in cells with FLT3 internal tandem duplicationMario Scarpa, Maria R. Baer|Oncotarget|2021Cited by 3